Biogen Idec (BIIB) option implied volatility at 25 into Rituxan Safety Warning

December 19, 2006 7:55 AM EST Send to a Friend
Biogen Idec (Nasdaq: BIIB) : BIIB & DNA's Rituxan drug to treat lupus has resulted in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login